Transform the world from your lab

Editorial
In vitro up-regulation of expression of GITR on human CD8 + cells
Yasmin Thanavala
Glucocorticoid-induced TNFR-related protein (GITR also known as TNFRSF18), a member of the tumor necrosis factor superfamily (TNFSF), is expressed on many cells of the innate and adaptive immune system.



[ABSTRACT] | [FULL TEXT] | [PDF]


Original Article
High risk of essential hypertension in males with intron 4 VNTR polymorphism of eNOS gene
Sushma Patkar, BH Charita, C Ramesh, T Padma
In this study 250 patients with essential hypertension were investigated in comparison to 218 normotensives for association with epidemiological parameters. Of these DNA samples from 176 patients and ...
[ABSTRACT] | [FULL TEXT] | [PDF]
Original Article
Linkage analysis of three families with arrythmogenic right ventricular cardiomyopathy in India
Maithili V. N. Dokuparthi, Pranathi R Pamuru, Sai S Oruganti, Narsimhan Calambur, Pratibha Nallari
Background: Arrythmogenic Right Ventricular Cardiomyopathy (ARVC) is a primary myocardial disorder morphologically characterized by subtle to severe replacement of the right ventricular myocar...
[ABSTRACT] | [FULL TEXT] | [PDF]

 

Instructions to Authors

Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journal” developed by International Committee of Medical Journal Editors (February 2006). The uniform requirements and specific requirement of Indian Journal of Human Genetics are summarised below. Before sending a manuscript contributors are requested to check for the latest instructions available. Instructions are also available from the website of the journal (https://www.ijhg.com/) and from the manuscript submission site (http://www.journalonweb.com/ijhg).


Secured

Explain how this feature benefits your research in simple terms.

All-in-one biotech solutions

Clear communication – we believe in providing transparent and easy-to-understand information to our patients and partners.

User-friendly interfaces

Discover how this feature can accelerate your research in just a few words.

50,000 patients have already benefited from our life-changing treatments.

Join us and revolutionize the biotech industry.